Advanced Search
Current and Breaking News for Professionals, Consumers and Media

Click here to learn how to advertise on this site and for ad rates.

FDA Approval Author: FDA Consumer Health Information Last Updated: Sep 7, 2017 - 10:06:33 PM

GenomeTrakr Helps FDA Identify Dangerous Bacteria

By FDA Consumer Health Information
Jun 2, 2014 - 11:34:15 AM

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon Sign up for our Ezine
For Email Marketing you can trust

Email this article
 Printer friendly page

( - Whole  genome sequencing is a cutting-edge technology that FDA has put to a novel and health-promoting use: supporting investigations of outbreaks of foodborne illnesses. The technology works by looking at the DNA fingerprint left behind by disease-causing bacteria, allowing FDA to identify the source of a foodborne outbreak with more detail and clarity than ever before.

The extraordinary benefit of this new technology, first adapted to outbreak investigations in the United States by the Food and Drug Administration (FDA), was recently demonstrated when it was used to help confirm the source of a strain of Listeria responsible for a multi-state outbreak linked to Hispanic-style cheese products. On March 11, 2014,  FDA suspended the registration of  the facility that manufactured the cheese products after some of its cheese products tested positive for a strain of Listeria indistinguishable from the one involved in the outbreak investigation.

Read the Consumer Update to learn more about their research and its implications on the safety of the food you eat.

FDA Consumer Updates may be posted and published elsewhere without permission. Please credit "FDA Consumer Health Information" as the source. FDA values feedback on its consumer health information. Send questions, comments or story ideas to: [email protected].

Sign up for e-mail notices of new FDA Consumer Updates.

View the FDA Consumer Update RSS feed.


For advertising/ promotion on, call Mike McCurdy at: 877-634-9180, or email at: [email protected] We have over 7,000 journalists as subscribers who can use our content.


Top of Page

FDA Approval
Latest Headlines

+ FDA Warns About Illegal Use of Injectable Silicone for Body Contouring and Associated Health Risks
+ FDA Warns of Potential Contamination in Multiple Brands of Drugs, Dietary Supplements
+ FDA Approves New Treatment to Reduce the Risk of Breast Cancer Returning
+ FDA Unveils Plan to Eliminate Orphan Designation Backlog
+ FDA Investigates Findings of Hepatitis A Linked to Frozen Tuna
+ FDA Approves New Novo Nordisk Treatment for Patients with Hemophilia
+ FDA Approves First Cancer Treatment for Any Solid Tumor With a Specific Genetic Feature
+ FDA Approves Drug to Treat ALS
+ FDA Approves Urea Cycle Disorder Treatment for Use in Children as Young as Two Months
+ Novartis Receives FDA Approval for Rydapt® in Newly Diagnosed FLT3-mutated Acute Yeloid Leukemia (AML)

Contact Us | Job Listings | Help | Site Map | About Us
Advertising Information | HND Press Release | Submit Information | Disclaimer

Site hosted by Sanchez Productions